TY - JOUR
T1 - Hybrid materials and nanocomposites as multifunctional biomaterials
AU - Follmann, Heveline D.M.
AU - Naves, Alliny F.
AU - Araujo, Rafael A.
AU - Dubovoy, Viktor
AU - Huang, Xiaoxi
AU - Asefa, Tewodros
AU - Silva, Rafael
AU - Oliveira, Osvaldo N.
N1 - Publisher Copyright:
© 2017 Bentham Science Publishers.
PY - 2017
Y1 - 2017
N2 - This review article provides an overview of hybrid and nanocomposite materials used as biomaterials in nanomedicine, focusing on applications in controlled drug delivery, tissue engineering, biosensors and theranostic systems. Special emphasis is placed on the importance of tuning the properties of nanocomposites, which can be achieved by choosing appropriate synthetic methods and seeking synergy among different types of materials, particularly exploiting their nanoscale nature. The challenges in fabrication for the nanocomposites are highlighted by classifying them as those comprising solely inorganic phases (inorganic/inorganic hybrids), organic phases (organic/organic hybrids) and both types of phases (organic/inorganic hybrids). A variety of examples are given for applications from the recent literature, from which one may infer that significant developments for effective use of hybrid materials require a delicate balance among structure, biocompatibility, and stability.
AB - This review article provides an overview of hybrid and nanocomposite materials used as biomaterials in nanomedicine, focusing on applications in controlled drug delivery, tissue engineering, biosensors and theranostic systems. Special emphasis is placed on the importance of tuning the properties of nanocomposites, which can be achieved by choosing appropriate synthetic methods and seeking synergy among different types of materials, particularly exploiting their nanoscale nature. The challenges in fabrication for the nanocomposites are highlighted by classifying them as those comprising solely inorganic phases (inorganic/inorganic hybrids), organic phases (organic/organic hybrids) and both types of phases (organic/inorganic hybrids). A variety of examples are given for applications from the recent literature, from which one may infer that significant developments for effective use of hybrid materials require a delicate balance among structure, biocompatibility, and stability.
KW - Drug delivery systems
KW - Hybrid materials
KW - Inorganic hybrids
KW - Multifunctional biomaterials
KW - Nanocomposites
KW - Theranostic systems
UR - http://www.scopus.com/inward/record.url?scp=85033395989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033395989&partnerID=8YFLogxK
U2 - 10.2174/1381612823666170710160615
DO - 10.2174/1381612823666170710160615
M3 - Review article
C2 - 28699525
AN - SCOPUS:85033395989
SN - 1381-6128
VL - 23
SP - 3794
EP - 3813
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 26
ER -